Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.
Linezolid is not yet recognized as a standard therapy for infective endocarditis but its use becomes a necessity when infection is due to multidrug-resistant microorganisms. This report describes 1 patient with endocarditis treated with linezolid and 45 similar cases from the medical literature.
Mancino
Paola
P
Clinic of Infectious Diseases, Centre of Excellence on Ageing, University 'G. d'Annunzio' School of Medicine, Chieti-Pescara, Italy.
Ucciferri
Claudio
C
Falasca
Katia
K
Pizzigallo
Eligio
E
Vecchiet
Jacopo
J
D000081:Acetamides / Q000627:therapeutic use*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance / Q000187:drug effects*; D023303:Oxazolidinones / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013212:Staphylococcus epidermidis / Q000187:drug effects* / Q000472:pathogenicity
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid